Trial Information

Summary: Insomnia?

Trouble sleeping? Wake up during the night?

  • Does it take you at least 30 minutes to fall asleep?
  • Are you sleeping 6 1/2 hours or less at least 3 nights per week?
  • When you wake up during the night, does it take you at least 60 minutes to fall asleep again?
  • Have you been experiencing this for at least 30 days?

A nationwide study is currently being conducted on an investigational medication for patients with Insomnia. If you are in good health and are 18 to 65 years old, you may qualify to participate in this research study.

Qualified participants will receive study medication and study related cars at no cost. If you or someone you know suffers from Insomnia, or would like more information about participating in this important research study...

Contact:

Oregon Center for Clinical Investigations, Inc. - Portland
2230 NW Pettygrove Street, Suite 120
Portland, OR 97210
Telephone: 503-276-6224
Fax: 503-276-6225
Email:

Profile Page: Oregon Center for Clinical Investigations, Inc. - Portland, Portland, OR

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:31 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA